Plasmodium Immunotherapy for Advanced Malignant Solid Tumors
Clinical trial NCT04165590 · RECRUITING
Trial details
- NCT number
- NCT04165590
- Sponsor
- CAS Lamvac Biotech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-24
- Primary completion
- 2024-04-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.